Skip to main content
Top
Published in: Maternal and Child Health Journal 5/2008

01-09-2008

Women Identified with HIV at Labor and Delivery: Testing, Disclosing and Linking to Care Challenges

Authors: Mardge H. Cohen, Yolanda Olszewski, Mayris P. Webber, Nancy Blaney, Patricia Garcia, Robert Maupin, Steven Nesheim, Denis Agniel, Susan P. Danner, Margaret A. Lampe, Marc Bulterys

Published in: Maternal and Child Health Journal | Issue 5/2008

Login to get access

Abstract

Objective To determine if women with undocumented HIV status in late pregnancy or at labor and delivery who are rapidly tested and identified as HIV infected have high-risk behaviors and psychosocial obstacles hindering postpartum follow-up. Methods Consenting participants (women with undocumented HIV status and ≥24 weeks gestational age (GA) and imminent delivery or ≥34 weeks GA) in 6 cities were rapidly tested and interviewed. HIV-positive women were offered follow-up. Results From 2001–2005, 54 HIV-infected women were identified: median age 26 years; 91% African American; 11 (20%) lost custody of their infants; 30 (56%) knew they or their partner were HIV-infected, but had no antenatal HIV care; 25 met criteria for starting antiretroviral therapy. Comparison between 48 HIV-infected and 130 HIV-negative women, tested and interviewed at the same hospitals, showed HIV-infected women more likely to be African American (P < .01) and report no prenatal care (P < .001), use street drugs (P < .01), have unstable residency (P < .05), not live with the father of their infant (P < .001), and have children in foster care (P < .01). Sixteen women (30%) and 17 (31%) infants did not remain in follow-up study due to relocation, child protective custody, and psychosocial issues including frequent substance use. Conclusion Over half of HIV-infected women knew they or their partner were infected with HIV, but did not initially disclose their status. Increased support services and substance abuse treatment are critical to facilitate better continuity of care for these socially marginalized women.
Literature
1.
go back to reference Watts, D. H. (2002). Management of human immunodeficiency virus infection in pregnancy. The New England Journal of Medicine, 346, 1879–1891.PubMedCrossRef Watts, D. H. (2002). Management of human immunodeficiency virus infection in pregnancy. The New England Journal of Medicine, 346, 1879–1891.PubMedCrossRef
2.
go back to reference Advancing HIV prevention: new strategies for a changing epidemic—United States, (2003). MMWR Morbidity and Mortality Weekly Report, 52, 329–332. Advancing HIV prevention: new strategies for a changing epidemic—United States, (2003). MMWR Morbidity and Mortality Weekly Report, 52, 329–332.
3.
go back to reference ACOG Committee Opinion No. 304 Prenatal and Perinatal Human Immunodeficiency Virus Testing: Expanded Recommendations, (2004). Obstetetrics and Gynecolgy, 104, 1119–1124. ACOG Committee Opinion No. 304 Prenatal and Perinatal Human Immunodeficiency Virus Testing: Expanded Recommendations, (2004). Obstetetrics and Gynecolgy, 104, 1119–1124.
4.
go back to reference American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Joint statement on human immunodeficiency virus screening. ACOG Policy Statement 75, Elk Grove Village (IL): AAP; Washington, DC: ACOG; 1999. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Joint statement on human immunodeficiency virus screening. ACOG Policy Statement 75, Elk Grove Village (IL): AAP; Washington, DC: ACOG; 1999.
5.
go back to reference Wilson, T. E., Ickovics, J. R., Royce, R., Fernandez, M. I., Lampe, M., & Koenig, L. J. (2004). Prenatal care utilization and the implementation of prophylaxis to prevent perinatal HIV-1 transmission. Maternal and Child Health Journal, 8, 13–18.PubMedCrossRef Wilson, T. E., Ickovics, J. R., Royce, R., Fernandez, M. I., Lampe, M., & Koenig, L. J. (2004). Prenatal care utilization and the implementation of prophylaxis to prevent perinatal HIV-1 transmission. Maternal and Child Health Journal, 8, 13–18.PubMedCrossRef
6.
go back to reference Peters, V., Liu, K. L., Gill, B., Thomas, P., Dominguez, K., Frederick, T. et al. (2003). Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996–2000, pediatric spectrum of HIV disease cohort. Pediatrics, 111, 1186–1191.PubMedCrossRef Peters, V., Liu, K. L., Gill, B., Thomas, P., Dominguez, K., Frederick, T. et al. (2003). Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996–2000, pediatric spectrum of HIV disease cohort. Pediatrics, 111, 1186–1191.PubMedCrossRef
7.
go back to reference CDC. (2004). Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital—Atlanta, Georgia, 1997–2000. MMWR Morbidity and Mortality Weekly Report, 52, 1245–1248. CDC. (2004). Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital—Atlanta, Georgia, 1997–2000. MMWR Morbidity and Mortality Weekly Report, 52, 1245–1248.
8.
go back to reference Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet (2002). 359, 1178–1186. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet (2002). 359, 1178–1186.
9.
go back to reference Guay, L. A., Musoke, P., Fleming, T., Bagenda, D., Allen, M., Nakabiito, C. et al. (1999). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 354, (9181), 795–802.PubMedCrossRef Guay, L. A., Musoke, P., Fleming, T., Bagenda, D., Allen, M., Nakabiito, C. et al. (1999). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 354, (9181), 795–802.PubMedCrossRef
10.
go back to reference Bulterys, M., Jamieson, D. J., O’Sullivan, M. J., Cohen, M. H., Maupin, R., Nesheim, S. et al. (2004). For the MIRIAD study group. rapid HIV-1 testing during labor: A multicenter study. JAMA, 292, 219–223.PubMedCrossRef Bulterys, M., Jamieson, D. J., O’Sullivan, M. J., Cohen, M. H., Maupin, R., Nesheim, S. et al. (2004). For the MIRIAD study group. rapid HIV-1 testing during labor: A multicenter study. JAMA, 292, 219–223.PubMedCrossRef
11.
go back to reference Cohen, M. H., Olszewski, Y., Branson, B., Robey, M., Love, F., Jamieson, D. et al. (2003). For the MIRIAD study group using point-of-care testing to make rapid HIV-1 tests in labor really rapid. AIDS, 17, 2121–2124.PubMedCrossRef Cohen, M. H., Olszewski, Y., Branson, B., Robey, M., Love, F., Jamieson, D. et al. (2003). For the MIRIAD study group using point-of-care testing to make rapid HIV-1 tests in labor really rapid. AIDS, 17, 2121–2124.PubMedCrossRef
12.
go back to reference Melchior, L., Huba, G. J., Brown, V. B., & Reback, C. J. (1993). A short depression index for women. Education and Psychological Measurement, 53, 1117–1126.CrossRef Melchior, L., Huba, G. J., Brown, V. B., & Reback, C. J. (1993). A short depression index for women. Education and Psychological Measurement, 53, 1117–1126.CrossRef
13.
go back to reference Yeni, P. G., Hammer, S. M., Hirsch, M. S., Saag, M. S., Schechter, M., Carpenter, C. C. et al. (2004). Treatment for adult HIV infection 2004 recommendations of the international AIDS society-USA panel. JAMA, 292, 251–265.PubMedCrossRef Yeni, P. G., Hammer, S. M., Hirsch, M. S., Saag, M. S., Schechter, M., Carpenter, C. C. et al. (2004). Treatment for adult HIV infection 2004 recommendations of the international AIDS society-USA panel. JAMA, 292, 251–265.PubMedCrossRef
14.
go back to reference Centers for Disease Control, Prevention. (2002). Progress toward elimination of perinatal HIV infection–Michigan, 1993–2000. MMWR Morbidity and Mortality Weekly Report, 51, 93–97. Centers for Disease Control, Prevention. (2002). Progress toward elimination of perinatal HIV infection–Michigan, 1993–2000. MMWR Morbidity and Mortality Weekly Report, 51, 93–97.
15.
go back to reference Mayaux, M. J., & Teglas, J. P. (2003). Blanche S for French pediatric HIV infection study group. characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French perinatal cohort. Journal of Acquired Immune Deficiency Syndromes, 34, 338–343.PubMedCrossRef Mayaux, M. J., & Teglas, J. P. (2003). Blanche S for French pediatric HIV infection study group. characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French perinatal cohort. Journal of Acquired Immune Deficiency Syndromes, 34, 338–343.PubMedCrossRef
16.
go back to reference Lindau, S. T., Jerome, J., Miller, K., Monk, E., Garcia, P., & Cohen, M. (2006). Mothers on the margins: Implications for eradicating perinatal HIV. Social Science and Medicine, 62, 59–69.PubMedCrossRef Lindau, S. T., Jerome, J., Miller, K., Monk, E., Garcia, P., & Cohen, M. (2006). Mothers on the margins: Implications for eradicating perinatal HIV. Social Science and Medicine, 62, 59–69.PubMedCrossRef
17.
go back to reference Beck, L. F., Morrow, B., Lipscomb, L. E., Johnson, C. H., Gaffield, M. E., Rogers, M. et al. (2002). Prevalence of selected maternal behaviors and experiences, pregnancy risk assessment monitoring system (PRAMS), 1999. MMWR Surveillance Summaries, 51(2), 1–27. Beck, L. F., Morrow, B., Lipscomb, L. E., Johnson, C. H., Gaffield, M. E., Rogers, M. et al. (2002). Prevalence of selected maternal behaviors and experiences, pregnancy risk assessment monitoring system (PRAMS), 1999. MMWR Surveillance Summaries, 51(2), 1–27.
19.
go back to reference York, R., Tulman, L., & Brown, K. (2000). Postnatal care in low-income urban Afrrican American women: relationship to level of prenatal care sought. Journal of Perinatology, 20, 34–40.PubMedCrossRef York, R., Tulman, L., & Brown, K. (2000). Postnatal care in low-income urban Afrrican American women: relationship to level of prenatal care sought. Journal of Perinatology, 20, 34–40.PubMedCrossRef
20.
go back to reference Kogan, M. D., Alexander, G. R., Jack, B. W., & Allen, M. C. (1998). The association between adequacy of prenatal care utilization and subsequent pediatric care utilization in the United States. Pediatrics, 102, 25–30.PubMedCrossRef Kogan, M. D., Alexander, G. R., Jack, B. W., & Allen, M. C. (1998). The association between adequacy of prenatal care utilization and subsequent pediatric care utilization in the United States. Pediatrics, 102, 25–30.PubMedCrossRef
21.
go back to reference Williams, L. M., Morrow, B., Lansky, A., Barfield, W. D., Prince, C. B., Marchi, K. S. et al. (2000). Surveillance for selected maternal behaviors and experiences before, during, and after pregnancy. Pregnancy risk assessment monitoring system (PRAMS). MMWR Surveillance Summaries, 52(11):1–14. Williams, L. M., Morrow, B., Lansky, A., Barfield, W. D., Prince, C. B., Marchi, K. S. et al. (2000). Surveillance for selected maternal behaviors and experiences before, during, and after pregnancy. Pregnancy risk assessment monitoring system (PRAMS). MMWR Surveillance Summaries, 52(11):1–14.
22.
go back to reference McDavid, K., Li, J., & Lee, L. M. (2006). Racial and ethnic disparities in HIV diagnoses for women in the United States. JAIDS, 42, 101–107.PubMed McDavid, K., Li, J., & Lee, L. M. (2006). Racial and ethnic disparities in HIV diagnoses for women in the United States. JAIDS, 42, 101–107.PubMed
23.
go back to reference Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. July 6, 2006 AIDSinfo Web site (http://AIDSinfo.nih.gov). Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. July 6, 2006 AIDSinfo Web site (http://​AIDSinfo.​nih.​gov).
24.
go back to reference Centers for Disease Control and Prevention. (2006). Achievements in public health: reduction in perinatal transmission of HIV infection—United States, 1985–2005. MMWR Morbidity and Mortality Weekly Report, 55, 592–597. Centers for Disease Control and Prevention. (2006). Achievements in public health: reduction in perinatal transmission of HIV infection—United States, 1985–2005. MMWR Morbidity and Mortality Weekly Report, 55, 592–597.
Metadata
Title
Women Identified with HIV at Labor and Delivery: Testing, Disclosing and Linking to Care Challenges
Authors
Mardge H. Cohen
Yolanda Olszewski
Mayris P. Webber
Nancy Blaney
Patricia Garcia
Robert Maupin
Steven Nesheim
Denis Agniel
Susan P. Danner
Margaret A. Lampe
Marc Bulterys
Publication date
01-09-2008
Publisher
Springer US
Published in
Maternal and Child Health Journal / Issue 5/2008
Print ISSN: 1092-7875
Electronic ISSN: 1573-6628
DOI
https://doi.org/10.1007/s10995-007-0265-5

Other articles of this Issue 5/2008

Maternal and Child Health Journal 5/2008 Go to the issue